{
  "guideline": {
    "id": "PA166246301",
    "name": "Annotation of FDA Label for acetaminophen / caffeine / dihydrocodeine and CYP2D6",
    "source": "FDA",
    "version": 5,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166246301",
    "relatedChemicals": [
      {
        "id": "PA166246281",
        "name": "acetaminophen / caffeine / dihydrocodeine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA128",
        "name": "cytochrome P450 family 2 subfamily D member 6",
        "symbol": "CYP2D6"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166312462",
      "name": "Recommendation Annotation PA166312462",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216761,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312504",
      "name": "Recommendation Annotation PA166312504",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216803,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312464",
      "name": "Recommendation Annotation PA166312464",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216763,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312482",
      "name": "Recommendation Annotation PA166312482",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216781,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312548",
      "name": "Recommendation Annotation PA166312548",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216847,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312502",
      "name": "Recommendation Annotation PA166312502",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216801,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥5.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312542",
      "name": "Recommendation Annotation PA166312542",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216841,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312544",
      "name": "Recommendation Annotation PA166312544",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216843,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312546",
      "name": "Recommendation Annotation PA166312546",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216845,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312465",
      "name": "Recommendation Annotation PA166312465",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216764,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312461",
      "name": "Recommendation Annotation PA166312461",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216760,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312503",
      "name": "Recommendation Annotation PA166312503",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216802,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312463",
      "name": "Recommendation Annotation PA166312463",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216762,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312481",
      "name": "Recommendation Annotation PA166312481",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216780,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.25"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312547",
      "name": "Recommendation Annotation PA166312547",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216846,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312483",
      "name": "Recommendation Annotation PA166312483",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216782,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312549",
      "name": "Recommendation Annotation PA166312549",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216848,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥6.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312501",
      "name": "Recommendation Annotation PA166312501",
      "population": "adults",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216800,
        "html": "<p>&quot;Individuals who are ultra-rapid metabolizers should not use codeine.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥4.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312543",
      "name": "Recommendation Annotation PA166312543",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216842,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312545",
      "name": "Recommendation Annotation PA166312545",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216844,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "≥3.5"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312521",
      "name": "Recommendation Annotation PA166312521",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216820,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "2.75"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166312541",
      "name": "Recommendation Annotation PA166312541",
      "population": "pediatrics",
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166246281",
          "name": "acetaminophen / caffeine / dihydrocodeine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216840,
        "html": "<p>&quot;Ultra-Rapid Metabolism of Codeine and Other Risk Factors for Life-threatening Respiratory Depression in Children.\nLife-threatening respiratory depression and death have occurred in children who received codeine. Most of the reported cases occurred following tonsillectomy and/or adenoidectomy, and many of the children had evidence of being an ultra-rapid metabolizer of codeine due to CYP2D6 polymorphism.&quot; See label for more information</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2D6": "3.0"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": true,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product Acetaminophen, Caffeine, Dihydrocodeine Bitartrate (Acetaminophen, Caffeine, Dihydrocodeine Bitartrate), ANDA204785, Xspire Pharma, Llc",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=204785"
    }
  ],
  "version": "2024-02-29-20-19"
}